Accessibility Tools

Skip to main content

Rheumatology Master List of Peer Reviewed Studies (immunology)

14 November 2021

Immune mediated disease flares: https://pubmed.ncbi.nlm.nih.gov/33946748/

Systemic lupus following vaccination: https://pubmed.ncbi.nlm.nih.gov/34418261/

Relapse of class V lupus. Nephritis after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34352310/

Lupus exacerbation: https://onlinelibrary.wiley.com/doi/10.1111/dth.15017

Lupus exacerbation following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34291477/

Rash, arthritis, swelling, muscle weakness following AstraZeneca: https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.27175

Reactivation of IgA vasculitis following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260100/

New onset mainly guttate psoriasis after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34309932/

14 cases of psoriasis activation following vaccination (Moderna, Pfizer, and AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34363647/

Pustuluar psoriasis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34398977/

Arthritis in the L elbow following vaccination: https://pubmed.ncbi.nlm.nih.gov/34363344/

Remitting seronegative symmetrical synovitis with pitting edema following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34348912/

Scleroderma renal crisis following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34339745/

Adult onset Still’s disease following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34316728/

Adult onset Still’s disease following mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34316726/

11% of patients with rheumatic and MSK diseases report disease flare following 2 dose mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34346185/

Antibodies mimicking the virus may explain long haul COVID-19, rare vaccine side effects: https://medicalxpress.com/news/2021-11-antibodies-mimicking-virus-haul-covid-.html